Your cells depend on the ZFYVE26 gene when they need to recycle and move materials inside the cell, which is especially important in long nerve cells. When it does not work properly, those nerves may gradually struggle to stay healthy. Pathogenic variants in both copies of the ZFYVE26 gene can cause SPG15, a form of hereditary spastic paraplegia, often linked to leg stiffness, weakness, and trouble walking. Some people may also have changes in vision, thinking, or bladder control.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, the parts of cells that do the work. Other genes mainly help determine when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in LearnHub.
Overview
ZFYVE26Gene function
What if the gene works
The ZFYVE26 gene helps nerve cells recycle old cell material. It supports lysosomes, which are compartments that break down and reuse waste. This is especially important for keeping long nerve pathways working well.
Risk
What if the gene does not work
Variants in the ZFYVE26 gene can cause spastic paraplegia, with gradually increasing leg stiffness and weakness. Some people also have vision problems or learning difficulties, and variant severity can affect when symptoms start and how broad they are.
Treatment
What does that mean for your treatment
No ZFYVE26-specific treatment or drug selection approach is currently established for people with a pathogenic or loss-of-function variant in the ZFYVE26 gene. Care is guided by symptoms and supportive management rather than by a gene-targeted medicine.
Conditions associated with ZFYVE26
Gene function
What if the gene works
Inside your cells, the ZFYVE26 gene helps manage the flow of material into the cell’s recycling system. Its protein supports membrane traffic between compartments that sort, break down, and reuse worn out cell parts. This helps explain how the ZFYVE26 gene supports the cell recycling system that keeps cells working smoothly over time.
The ZFYVE26 gene helps move worn out cell material into the pathway that breaks it down and reuses it. This supports normal autophagy, the cell’s routine cleanup process.
After cell waste is broken down, ZFYVE26 helps rebuild fresh lysosomes, the compartments that digest and recycle material. This keeps the recycling system ready for the next round of cleanup.
Its protein helps guide membrane bound cargo between sorting compartments and lysosomes. This steady traffic lets cells send enzymes and other materials to the right place at the right time.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help create normal human diversity, including variations in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ZFYVE26 gene can affect protein function by reducing or removing spastizin, often through loss-of-function changes that stop the protein from being made in full. Some variants are milder and may leave a small amount of activity, while more severe variants can cause a near-complete loss. This disrupts autophagy (the cell's cleanup process) and membrane trafficking inside nerve cells. In SPG15, lower residual function often tracks with earlier onset or a wider range of symptoms.
How variants are linked to conditions
Pathogenic variants in the ZFYVE26 gene cause hereditary spastic paraplegia type 15, often called SPG15. This inherited condition mainly affects walking and leg stiffness, and some people also develop changes in vision, balance, or thinking over time. In clinical genetics, the clearest ZFYVE26 gene disease association is SPG15 rather than a broad range of unrelated conditions.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of human biology and are common throughout the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, carrying a variant linked to a condition indicates a possible association rather than a definite diagnosis, especially when multiple genes and environmental factors also play a role. In some situations, however, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ZFYVE26, risk is mainly shaped by genetics rather than lifestyle. People usually develop related health problems only when both copies of the ZFYVE26 gene have disease-causing changes, so family history and whether both parents carry a changed copy are the main factors that affect risk. There is not enough evidence to say that diet, exercise, or other daily habits change this genetic risk.
Inheritance of ZFYVE26 variants
ZFYVE26-related conditions are inherited in an autosomal recessive pattern. This means a person usually develops the condition only if they inherit two disease-causing variants in the ZFYVE26 gene, one from each parent. Parents who each carry one variant are usually unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with neither variant. In families asking about ZFYVE26 inheritance, this pattern affects sons and daughters equally.
What does my ZFYVE26 result mean for my family?
Changes in the ZFYVE26 gene are linked to a condition that usually runs in families in a recessive pattern. For family members, this often means parents may be healthy carriers, brothers and sisters could also be affected or be carriers, and other relatives may carry the same gene change without knowing it. Children of someone with a ZFYVE26-related condition are usually carriers unless the other parent also carries a change in the same gene.
Genetic information
Genetic testing
How you find out about variants
ZFYVE26 genetic testing usually uses a blood or saliva sample and reads the DNA code of the ZFYVE26 gene to look for variants. It is often done as part of a hereditary spastic paraplegia panel or exome sequencing, and results may show whether a variant helps explain a person’s symptoms.
When should I consider getting a genetic test?
Genetic testing for the ZFYVE26 gene may be worth considering in people with unexplained long-term leg stiffness, walking problems, or other signs of an inherited condition affecting movement, especially when similar symptoms run in the family. It can help confirm a diagnosis of a rare form of hereditary spastic paraplegia.
A genetic result is only one part of your health story
Genetic results can offer useful insight, but how much they explain depends on the condition and the specific type of variant involved. Many factors, including lifestyle, environment, age, and medical history, also shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This happens because the body can absorb, break down, transport, or respond to a drug a little differently from one person to another. These inherited differences are common and can influence how well a treatment works or how likely someone is to notice side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. It studies gene and drug patterns to help explain why the same treatment can work differently from one person to another. For many medicines, genes can affect both how strongly a drug works and how the body processes it. This information can support more informed, more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the ZFYVE26 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how people respond to medicines, so questions about side effects, treatment changes, or other health concerns are best discussed with your doctor.
History
ZFYVE26 entered medical genetics through studies of families with inherited walking difficulties later classified as SPG15, a form of hereditary spastic paraplegia. In recent decades, awareness of this gene’s role has grown as researchers connected changes in the ZFYVE26 gene with this condition. Early papers also used the name KIAA0321, and the protein was later widely referred to as spastizin. From these first observations, research expanded steadily, helping clinicians recognize that SPG15 could include more than leg stiffness alone. As genetic testing improved, the ZFYVE26 gene became part of broader testing panels for inherited nerve conditions. The way this gene was viewed has shifted over time, from an unnamed cause in affected families to a clearly identified gene in modern diagnostics.